Skip to content

Clinical trials

Active, not recruiting Lymphoma, B-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Active, not recruiting Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20201
20215
20223
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
Shanghai Junshi Bioscience Co., Ltd.2
Acerta Pharma BV1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Cothera Bioscience, Inc1
Daihong Liu1
Eli Lilly and Company1
Genmab1
Guangzhou Lupeng Pharmaceutical Company LTD.1
Han weidong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell17
Lymphoma, Non-Hodgkin8
Hematologic Diseases4
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma4
Lymphoma, Large B-Cell, Diffuse3
Burkitt Lymphoma2
Lymphatic Diseases2
Lymphoma, Mantle-Cell2
Neoplasms2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.